Both drugs are now at a stage of development, TMC-20 in patients with a first batch of test results showed that the drug is safe and effective. Another drug TMC-125 is expected to conduct human trials in the near future.
Dibotaike company's researchers said that although they in the lab has created a new drug may eventually resistance of the HIV variant, but tests showed that the virus on to their drug resistance needs at least A few years time, but also may never be drug-resistant form.
